April 1, 2022
Date: Apr 1, 2022
Duration: 20 Min
BioProcess Insider’s State of the Industry takes a deeper look into the recent business news affecting the biomanufacturing industry, picking apart the numbers and highlighting potential trends.
With a panel of industry experts, editor Dan Stanton discusses recent mergers and acquisitions in the bioprocess space, bottlenecks within the manufacturing sector, the continued head- and tailwinds COVID-19 is placing on businesses, and the evolution of the cell and gene therapy landscape and what that means for supply chains.
Panelists:
Frank Orlowski, Director of Business Development, Latham Biopharm Group
Steven Lee, CEO, Eden Biologics
Joe Scott, Vice President, Supply Chain Operations, Avid Bioservices
You May Also Like
